Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.
Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.
Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.
Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.
Three late-breaking VIVA26 studies reported new data on bleeding risk with ultrasound-facilitated catheter-directed thrombolysis, wearable-based functional recovery after intermediate-high-risk PE, and Laguna Thrombectomy System™ safety and...
Three late-breaking VIVA26 studies reported new data on bleeding risk with ultrasound-facilitated catheter-directed thrombolysis, wearable-based functional recovery after intermediate-high-risk PE, and Laguna Thrombectomy System™ safety and...
Six late-breaking VIVA26 studies reported new data on sirolimus-based balloon and resorbable scaffold therapies, as well as adjunctive pharmacologic treatment, for patients with PAD and chronic limb-threatening ischemia.
Six late-breaking VIVA26 studies reported new data on sirolimus-based balloon and resorbable scaffold therapies, as well as adjunctive pharmacologic treatment, for patients with PAD and chronic limb-threatening ischemia.
Mount Sinai will use the funding for a one-year feasibility phase of the United States portion of a major international clinical trial to determine whether aspirin alone or a more intensive combination of blood-thinning medications is better...
Mount Sinai will use the funding for a one-year feasibility phase of the United States portion of a major international clinical trial to determine whether aspirin alone or a more intensive combination of blood-thinning medications is better...
Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac...
Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac...
Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and anticoagulation alone translate to patients’ everyday recovery.
Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and anticoagulation alone translate to patients’ everyday recovery.
Key takeaways
Artificial intelligence (AI) offers major opportunities to improve health care, however, current use is fragmented.
To facilitate the uptake of AI in cardiovascular care, the European Cardiovascular Health...
Key takeaways
Artificial intelligence (AI) offers major opportunities to improve health care, however, current use is fragmented.
To facilitate the uptake of AI in cardiovascular care, the European Cardiovascular Health...
James Leung, MBBS; John French, MBChB, PhD; James Xu, MBBS, PhD; Kathryn Wales, MD; Hashim Kachwalla, MBBS; Krishna Kaddapu, MBBS, PhD; Sarah Fares, MPhil; Viet Dang, MBBS; Tamer Badie, MBBS; Christian Mussap, MBBS, PhD; Rohan Rajaratnam, MBBS; Dominic Leung, MBBS, PhD; Sidney Lo, MBBS; Craig Juergens, MBBS, DMedSc
This study compared visual, robotic, and intracoronary imaging lesion length measurements performed during robotic-assisted percutaneous coronary intervention cases enrolled in the PARTY trial.
This study compared visual, robotic, and intracoronary imaging lesion length measurements performed during robotic-assisted percutaneous coronary intervention cases enrolled in the PARTY trial.
Marco Angelillis, MD; Leonardo Misuraca, MD; Paolo Calabria, MD; Cristina Giannini, MD, PhD; Paolo Spontoni, MD; Laura Stazzoni, MD; Alessandro Sticchi, MD, PhD; Giulia Costa, MD, PhD; Marco De Carlo, MD, PhD
The article describes a novel bailout technique illustrated through a clinical case, the SAFE-SEAL (Suture-Assisted Femoral Emergency SEALing) technique, designed to achieve hemostasis following failure of the plug-based component of a hybrid...
The article describes a novel bailout technique illustrated through a clinical case, the SAFE-SEAL (Suture-Assisted Femoral Emergency SEALing) technique, designed to achieve hemostasis following failure of the plug-based component of a hybrid...
A 78-year-old man was admitted with non-ST-segment elevation myocardial infarction. He had a history of ischemic heart disease with prior percutaneous coronary intervention to the right coronary artery and mid-left anterior descending artery.
A 78-year-old man was admitted with non-ST-segment elevation myocardial infarction. He had a history of ischemic heart disease with prior percutaneous coronary intervention to the right coronary artery and mid-left anterior descending artery.
Maedeh Zokaei Nikoo, MD; Rafey Feroze, MD; Luis Augusto Palma Dallan, MD, PhD; Yusef Saeed, MD; Alexander Cove, MD; Abdullah Altorbag, MD; Andreas A. Towers, MD; Syed R. Nabi, MD; Harsh Amin, MD; Sabin Lama, MD; Christopher Mishreky, MD; Kareem Fanous, MD; Justin M. Dunn, MD; Vinicius Esteves, MD; Steven J. Filby, MD
The authors investigated the association between postprocedural antithrombotic regimen and compute tomography-derived device healing following WATCHMAN FLX Pro (Boston Scientific) implantation.
The authors investigated the association between postprocedural antithrombotic regimen and compute tomography-derived device healing following WATCHMAN FLX Pro (Boston Scientific) implantation.
The authors assessed the feasibility, technical considerations, and procedural safety of totally percutaneous transfemoral transcatheter aortic valve replacement via synthetic aortobifemoral bypass grafts.
The authors assessed the feasibility, technical considerations, and procedural safety of totally percutaneous transfemoral transcatheter aortic valve replacement via synthetic aortobifemoral bypass grafts.
A 74-year-old woman with dilated cardiomyopathy, marked left ventricular enlargement, and severe functional mitral regurgitation remained in decompensated heart failure despite dobutamine therapy. Coronary angiography showed no significant...
A 74-year-old woman with dilated cardiomyopathy, marked left ventricular enlargement, and severe functional mitral regurgitation remained in decompensated heart failure despite dobutamine therapy. Coronary angiography showed no significant...
A 20-year-old woman presented with resistant hypertension despite taking 3 antihypertensives. On examination, she had a blood pressure of 180/100 mm Hg and a systolic murmur heard under the left scapula.
A 20-year-old woman presented with resistant hypertension despite taking 3 antihypertensives. On examination, she had a blood pressure of 180/100 mm Hg and a systolic murmur heard under the left scapula.
Neeraj Shah, MD, MPH; Raveen Bazaz, MD; Bassel Sayegh, MD; Mitsugu Ogawa, MD; Dennis Phillips, MD; Benjamin Kristobak, MD
An 83-year-old man with diastolic heart failure, chronic atrial fibrillation on warfarin, severe atrial-functional mitral regurgitation, and a secundum atrial septal defect in an anterior/superior location underwent transcatheter edge-to-edge...
An 83-year-old man with diastolic heart failure, chronic atrial fibrillation on warfarin, severe atrial-functional mitral regurgitation, and a secundum atrial septal defect in an anterior/superior location underwent transcatheter edge-to-edge...
